Metastasiertes Melanom: LAG-3-Antikörper als Therapieoption
Crossref DOI link: https://doi.org/10.1007/s15015-022-3966-0
Published Online: 2022-09-01
Published Print: 2022-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Müller-Waldeck, Roland
Text and Data Mining valid from 2022-09-01
Version of Record valid from 2022-09-01
Article History
First Online: 1 September 2022
Free to read: This content has been made available to all.